Search results
King Charles III’s openness about cancer has helped him connect with people in year after coronation
Arizona Daily Star· 13 hours agoKing Charles III’s decision to be open about his cancer diagnosis has helped the new monarch connect...
Earnings call: Veracyte sees robust growth driven by diagnostics platform By Investing.com
Investing.com· 13 hours agoThe company's revenue reached $96.8 million, marking a 17% increase from the same period last year,...
Bipartisan congressional spouses tackle cancer prevention, and leave politics out
NPR· 17 hours agoSciences. That designation would unlock more resources, clinical trials and state of the art ...
Early onset bowel cancer cases increasing in New Zealand
Medical Xpress· 5 hours agoThe findings, published in BMC Cancer, show that while colorectal cancer rates (CRC) in older age groups have actually decreased (possibly in part due to ...
King Charles III’s openness about cancer has helped him connect with people in year after coronation
Journal Gazette & Times-Courier· 13 hours agoKing Charles III’s decision to be open about his cancer diagnosis has helped the new monarch connect...
King Charles III’s openness about cancer has helped him connect with people in year after coronation
Winston-Salem Journal· 13 hours agoKing Charles III’s decision to be open about his cancer diagnosis has helped the new monarch connect...
King Charles III’s openness about cancer has helped him connect with people in year after coronation
Wisconsin State Journal· 13 hours agoKing Charles III’s decision to be open about his cancer diagnosis has helped the new monarch connect...
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
GenomeWeb News· 6 days agoAngle announced on Friday that it has signed a supplier agreement with AstraZeneca to develop an androgen receptor (AR) assay to assess prostate cancer ...
King Charles III’s openness about cancer has helped him connect with people in year after coronation
La Crosse Tribune· 13 hours agoKing Charles III’s decision to be open about his cancer diagnosis has helped the new monarch connect...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
St. Louis Post-Dispatch· 5 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation ...